🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase

RecruitingNAAges 14 Years - 24 YearsAllPierre Fabre Dermo Cosmetique
NCT06716398 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In this study, we are interested in the global benefit of the tested product as complementary care to a topical medical treatment during a 3 month-associated treatment phase followed by a 3 month-maintenance phase, compared to a light moisturizing cream, in teenagers and adults with acne. We also want to evaluate the tolerance of the tested product in association and in maintenance of the topical medical treatment.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male or Female aged between 14 and 24 years (included) * Subject with facial acne with score index severity IGA = 2 or 3, assessed on a scale ranged from 0 to 4. * Subject for whom a prescription of 12 weeks of a reference topical medical treatment is required from the day of the inclusion visit, for mild to moderate face acne Exclusion Criteria: Criteria related to the disease: * Facial skin disease other than acne, skin abnormalities, or dermatological condition on the face liable to interfere with the study assessments * Acne conglobata, Acne fulminans, nodulocystic acne or acneiform eruptions, according to investigator's assessment * Other type of pigmentation disorder than acne-related PIH liable to interfere with the study assessments according to the investigator Criteria related to treatments and/or products: \- Topical or oral treatment established or modified during the previous weeks or planned to be established or modified during the study, liable to interfere with the evaluation of the efficacy or cutaneous tolerance of the investigational products
💊

What it tests

  • Test product
  • Comparator product
📍

Where

1 site
UNIFESP
São Paulo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy